Glia-Neuron GPCR Signaling as a Therapeutic Route to Axon Regeneration: cAMP-PKA Activation Elevates Excitability and Survival in Neurons
ISEF · 2026 Biomedical and Health Sciences
Overview
Nerve degeneration causes devastating symptoms for millions of patients worldwide. While some peripheral nerves experience recovery, others experience chronic neuropathic pain due to sensory neuron conditions, and CNS degeneration continues to be without a cure. The role of glial cells and intercellular signaling in the process of degeneration and regeneration still leaves many questions unanswered. This study investigated whether glia-derived prostaglandin E2 (PGE2) can be used to promote axon regeneration via GPCR/cAMP signaling, and focused on determining whether neuronal health and survivability improve following treatment. Treatment with 1 uM dimethyl-PGE2 (dmPGE2) significantly reduced apoptosis in a dose-dependent manner, with the lowest Annexin-V positivity at this dose. Toxicity emerged at 100 uM. RNAScope revealed that voltage-gated sodium channels were expressed at higher levels in injured cells treated with dmPGE2 than in untreated injured cells without causing hyperexcitability. To determine the role of this signaling in vivo, scRNA-seq from a spared-nerve-injured dorsal root ganglia dataset revealed that Schwann cells upregulate cAMP- and MAPK-pathways, while a damaged Mrgprd/Gm7271 nociceptor subset downregulates cAMP-associated genes and upregulates apoptotic pathways. Together, these findings suggest that glial PGE2, through Gs-coupled receptors, elevates neuronal cAMP/PKA signaling, boosting excitability and growth, potentially rescuing low-cAMP, pro-apoptotic neuronal states. This study identifies a potential signaling pathway that can be targeted to accelerate axon regeneration, making prostaglandin E2 treatment a viable therapeutic strategy that could improve lives.
Competition history
- ISEF 2026
Resources
Related projects
ISEF · 2025
Paving the Path to the Impossible: Regenerating Neurons Using Prostaglandin E2 Regulation as a Therapeutic Strategy
ISEF · 2014
Enabling Neural Regeneration in a Model of Glial Scarring: Implications of Enhancing Retinoic Acid Signaling and Regulating NG2 Expression
ISEF · 2021
Schwann Cell Support as a Novel Approach to Peripheral Nervous System Demyelinating Disease: A Phase Two Study
ISEF · 2022
A Novel Investigation of the Effects of EphA4 on Axon Regeneration in the Spinal Cord
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair